Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ternary complex therapy for autoimmune disease

C G Fathman1

  • 1Division of Immunology and Rheumatology, Stanford University Medical School, USA.

Hospital Practice (1995)
|August 15, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dengue-2 structural proteins associate with human proteins to produce a coagulation and innate immune response biased interactome.

BMC infectious diseases·2011
Same author

Preservation of self: an overview of E3 ubiquitin ligases and T cell tolerance.

Seminars in immunology·2007
Same author

Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis.

Gene therapy·2003
Same author

A complicated relationship: fulfilling the interactive needs of the T lymphocyte and the dendritic cell.

The pharmacogenomics journal·2003
Same author

Application of gene therapy in autoimmune disease.

Current directions in autoimmunity·2002
Same author

Bioluminescence imaging of lymphocyte trafficking in vivo.

Experimental hematology·2001

The immune response involves three key components: antigen, MHC class II, and CD4 T-cell receptors. Targeting these elements offers a novel strategy for treating autoimmune diseases with reduced toxicity.

Area of Science:

  • Immunology
  • Autoimmune disease research

Background:

  • Immune response induction relies on the interaction between processed antigen, MHC class II molecules, and CD4 T-cell receptors.
  • Current treatments for autoimmune diseases can have significant toxicities.

Purpose of the Study:

  • To identify novel therapeutic targets within the immune response induction pathway.
  • To explore the potential for developing specific, less toxic treatments for autoimmune conditions.

Main Methods:

  • Analysis of the ternary complex involved in immune response initiation.
  • Identification of the processed antigen, MHC class II molecule, and CD4 T-cell receptor as potential intervention points.

Main Results:

  • The interaction of processed antigen, MHC class II, and CD4 T-cell receptor forms a critical complex for immune response induction.

Related Experiment Videos

  • Each component of this ternary complex presents a viable target for therapeutic intervention.

    • Conclusions:

    • Targeting the components of the ternary complex offers a promising strategy for specific intervention in autoimmune diseases.
    • This approach has the potential to lead to treatments with lower toxicity compared to existing therapies.